Domov › Kolorektalni rak › Texas › Austin
Klinične študije za Kolorektalni rak v Austin, TX
19 študij za Kolorektalni rak išče udeležence na lokacijah v Austin in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Austin, Austin
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #46, Austin
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 2
- Texas Oncology - Austin Midtown /ID# 271354, Austin
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 2/3
- Texas Oncology, PA, Austin
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Vključevanje udeležencevFaza 3
- Ascension Seton Spclty Care Ctr, Austin
- Texas Oncology, Austin
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Vključevanje udeležencevFaza 3
- Texas Oncology-South Austin, Austin
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Vključevanje udeležencevFaza 1
- NEXT Austin, Austin
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Texas Oncology - Central/South Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Vključevanje udeležencevFaza 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Vključevanje udeležencevFaza 1
- NEXT Texas LLC - Austin, Austin
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Texas LLC - Austin, Austin
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Vključevanje udeležencevFaza 2
- Texas Oncology - Central/South Texas, Austin
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- University of Texas at Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Austin, TX 78758
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Elligo Health Research, Inc., Austin
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Natera, Inc, Austin
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Natera, Austin
Študije za Kolorektalni rak v drugih mestih
- Houston, TX102 študij
- New York City, NY78 študij
- Nashville, TN69 študij
- Boston, MA63 študij
- Los Angeles, CA59 študij
- Arlington, VA52 študij
- St. Louis, MO50 študij
- San Antonio, TX46 študij
- Philadelphia, PA44 študij
- Grand Rapids, MI40 študij
- Baldwin Park, CA37 študij
- Chicago, IL34 študij
Druge študije v Austin
- Nemalicelični pljučni rak30 študij
- Rak (vse vrste)20 študij
- Debelost20 študij
- Metastatski rak19 študij
- Prekomerna telesna teža18 študij
- Srčno popuščanje18 študij
- Rak dojke18 študij
- Rak jajčnikov17 študij
- Rak endometrija15 študij
- Rak prostate15 študij
- Depresija14 študij
- Shizofrenija13 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.